{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:39:33Z","timestamp":1777927173949,"version":"3.51.4"},"reference-count":25,"publisher":"Georg Thieme Verlag KG","issue":"01","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Nucl Med"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Clear cell sarcoma (CCS) and malignant melanoma share overlapping immunohistochemical profiles, particularly SOX10 and HMB45 positivity, making histopathological differentiation challenging. Distinguishing between these entities is clinically essential due to their differing prognoses and therapeutic approaches. This case highlights how fluorine-18 fluorodeoxyglucose positron emission tomography\/computed tomography (18F-FDG PET\/CT) contributed decisively to establishing the diagnosis of CCS by following a pathologist-recommended diagnostic algorithm. A 70-year-old male presented with a progressively enlarging left scapular mass. Tru-cut biopsy revealed a malignant neoplasm positive for SOX10 and HMB45, with immunohistochemistry insufficient to differentiate CCS from metastatic melanoma. The pathology report recommended a search for a primary cutaneous melanoma, indicating that in the absence of such a lesion, the diagnosis should favor CCS. Whole-body 18F-FDG PET\/CT demonstrated extensive metastatic disease involving the lungs, left adrenal gland, T11 vertebra, scapula, and a large presacral mass. Critically, no hypermetabolic cutaneous, mucosal, or nodal lesions suggestive of a primary melanoma were identified. Comprehensive dermatological evaluation was also negative for suspicious melanocytic lesions. Based on the diagnostic algorithm, histopathology, plus exclusion of a primary melanoma, the PET\/CT findings supported the diagnosis of metastatic CCS. This case demonstrates that 18F-FDG PET\/CT can serve as a diagnostic tool when histopathology alone is inconclusive. The absence of a primary melanoma on whole-body 18F-FDG PET\/CT and clinical examination was the decisive factor favoring CCS over melanoma of unknown primary. This case underscores the limitations of MRI, which often describes CCS as a well-defined, benign-appearing mass, potentially delaying accurate diagnosis.<\/jats:p>","DOI":"10.1055\/s-0046-1819651","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:10:21Z","timestamp":1774483821000},"page":"093-100","source":"Crossref","is-referenced-by-count":0,"title":["FDG PET\/CT as the Decisive Modality in Distinguishing Clear Cell Sarcoma from Melanoma When Immunohistochemistry Overlaps: A Case Report"],"prefix":"10.1055","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4694-5850","authenticated-orcid":false,"given":"Efrah Ahmed","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Bursa Uluda\u011f University Hospital, Bursa, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eray","family":"Alper","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Bursa Uluda\u011f University Faculty of Medicine, Bursa, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/1097-0142(196509)18:9<1163::AID-CNCR2820180916>3.0.CO;2-0","article-title":"Clear-cell sarcoma of tendons and aponeuroses. An analysis of 21 cases","volume":"18","author":"F M Enzinger","year":"1965","journal-title":"Cancer"},{"issue":"05","key":"ref2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00000478-198307000-00003","article-title":"Malignant melanoma of soft parts. A reassessment of clear cell sarcoma","volume":"7","author":"E B Chung","year":"1983","journal-title":"Am J Surg Pathol"},{"issue":"04","key":"ref3","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3390\/jcm14041233","article-title":"Clear cell sarcoma (CCS) of the soft tissue: a review","volume":"14","author":"G Cazzato","year":"2025","journal-title":"J Clin Med"},{"issue":"03","key":"ref4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/PAS.0b013e31814b18fb","article-title":"Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases","volume":"32","author":"M Hisaoka","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"16","key":"ref5","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"J Larkin","year":"2019","journal-title":"N Engl J Med"},{"issue":"07","key":"ref6","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1056\/NEJMoa1904059","article-title":"Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma","volume":"381","author":"C Robert","year":"2019","journal-title":"N Engl J Med"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/ng.3399","article-title":"SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas","volume":"47","author":"F Le Loarer","year":"2015","journal-title":"Nature Genetics"},{"issue":"03","key":"ref8","doi-asserted-by":"crossref","first-page":"100522","DOI":"10.1016\/j.esmoop.2022.100522","article-title":"Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma Network","volume":"7","author":"A Smrke","year":"2022","journal-title":"ESMO Open"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2014.09.029","article-title":"Metastatic melanomas of unknown primary show better prognosis than those of known primary: a systematic review and meta-analysis of observational studies","volume":"72","author":"J M Bae","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnci\/djq455","article-title":"Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis","volume":"103","author":"Y Xing","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0899-7071(02)00493-X","article-title":"MR findings of clear cell sarcoma: two case reports","volume":"27","author":"H Isoda","year":"2003","journal-title":"Clin Imaging"},{"issue":"04","key":"ref12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s002560050592","article-title":"MR imaging of clear cell sarcoma (malignant melanoma of the soft parts): a multicenter correlative MRI-pathology study of 21 cases and literature review","volume":"29","author":"L H De Beuckeleer","year":"2000","journal-title":"Skeletal Radiol"},{"issue":"05","key":"ref13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5306\/wjco.v10.i5.213","article-title":"Clear cell sarcoma in unusual sites mimicking metastatic melanoma","volume":"10","author":"I E Obiorah","year":"2019","journal-title":"World J Clin Oncol"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40644-021-00440-4","article-title":"PET\/CT variants and pitfalls in malignant melanoma","volume":"22","author":"N Aide","year":"2022","journal-title":"Cancer Imaging"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/cncr.22380","article-title":"Clear cell sarcoma of tendons and aponeuroses: a study of 75 patients","volume":"109","author":"A Kawai","year":"2007","journal-title":"Cancer"},{"key":"ref16","first-page":"647684","article-title":"Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors","volume":"2012","author":"F Tas","year":"2012","journal-title":"J Oncol"},{"issue":"06","key":"ref17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/RLU.0000000000004065","article-title":"18F-FDG PET\/CT in clear cell sarcoma with multiple bone metastases","volume":"47","author":"T Long","year":"2022","journal-title":"Clin Nucl Med"},{"issue":"09","key":"ref18","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/modpathol.2009.85","article-title":"Detection and characterization of EWSR1\/ATF1 and EWSR1\/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts)","volume":"22","author":"W L Wang","year":"2009","journal-title":"Mod Pathol"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1525-1578(10)60679-4","article-title":"Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases","volume":"4","author":"C R Antonescu","year":"2002","journal-title":"J Mol Diagn"},{"issue":"6892","key":"ref20","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"H Davies","year":"2002","journal-title":"Nature"},{"issue":"30","key":"ref21","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1200\/JCO.23.01136","article-title":"Systemic therapy for melanoma: ASCO guideline update","volume":"41","author":"R Seth","year":"2023","journal-title":"J Clin Oncol"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jjco\/hyad083","article-title":"The current management of clear cell sarcoma","volume":"53","author":"K Ikuta","year":"2023","journal-title":"Jpn J Clin Oncol"},{"issue":"16","key":"ref23","doi-asserted-by":"crossref","first-page":"e6713","DOI":"10.1097\/MD.0000000000006713","article-title":"18F-FDG PET\/CT for detection of the primary tumor in adults with extracervical metastases from cancer of unknown primary: a systematic review and meta-analysis","volume":"96","author":"S A Burglin","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"09","key":"ref24","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.crad.2017.04.014","article-title":"Diagnostic yield of FDG-PET\/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise","volume":"72","author":"T Bharucha","year":"2017","journal-title":"Clin Radiol"},{"key":"ref25","first-page":"1371","article-title":"18F-FDG PET\/CT in the initial staging and restaging of soft tissue sarcoma","volume":"64","author":"U Metser","year":"2023","journal-title":"J Nucl Med"}],"container-title":["World Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0046-1819651.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:36:54Z","timestamp":1777675014000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0046-1819651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":25,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2026,5,1]]},"published-print":{"date-parts":[[2026,3]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0046-1819651","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1450-1147","1607-3312"],"issn-type":[{"value":"1450-1147","type":"print"},{"value":"1607-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}